Secondary and Adjunct Faculty
These secondary and adjunct faculty members complement the skills and expertise of our core, full-time pharmacology and physiology faculty.
Secondary Faculty
Wei Du, MD, MS
Professor and Academic Chair of Psychiatry
Interests: Clinical psychiatry
wd26@drexel.edu
Sandhya Kortagere, PhD
Professor, Department of Microbiology & Immunology; Vice Dean of Research and Innovation
Interests: Molecular pharmacology and drug discovery
sk673@drexel.edu
Andrea McCurry, MS
Executive Director, ULAR Operations
Interests: Laboratory animal care and supervision
ams34@drexel.edu
Jennifer Nasser, PhD, RD
Associate Professor, Nutrition Sciences, College of Nursing and Health Professions
Interests: Dopamine-mediated mechanisms for food intake over- and under-consumption in humans; effects of nutrients on memory and cognition in humans
jan57@drexel.edu
Sonia Navas-Martin, PhD
Professor, Department of Microbiology & Immunology
Interests: Human hepatitis C virus; coronaviruses
sn87@drexel.edu
Atom Sarkar, MD, PhD*
Professor, Department of Neurosurgery; Director, Neuro-Oncology and Adult & Pediatric Stereotactic, Functional and Epilepsy Surgery, Global Neurosciences Institute
Interests: Deep brain stimulation (tremor, pain, parkinson's disease), epilepsy surgery (adult and pediatric), brain tumors
asarkar@gnineuro.org
Daniel V. Schidlow, MD
Professor, Department of Pediatrics; Dean Emeritus
Interests: Cystic fibrosis and pulmonary conditions in children
ds46@drexel.edu
Back to Top
Adjunct Faculty
Adeboye Adajare, PhD
Professor, Department of Pharmaceutical Sciences, Saint Joseph’s University
Interests: Medicinal chemistry
aadejare@sju.edu
Vincent Aloyo, PhD
Interests: Serotonin, animal behavior
vincent.aloyo@gmail.com
Gilbert Block, MD, PhD*
Chief Medical Officer, Altpep
Interests: Central nervous system disorders and drug development
DrGilBlock@gmail.com
Elinor H. Cantor, PhD
Consultant
Interests: Pharmacology and consulting
ecantor@cjres.com
Samuel K. Chacko, DVM, PhD
Professor Emeritus, Pathobiology, School of Veterinary Medicine, University of Pennsylvania
Interests: Pathobiology of smooth muscle, signal transduction, myosin, thin filament-associated protein caldesmon, smooth muscle cell differentiation, translational research
chackosk@vet.upenn.edu
Janet Clark, PhD
Director for Fellowship Training, National Institute of Mental Health
janet.clark@nih.gov
Angelo Del Parigi, MD, MBA*
Medical Affairs Consultant; Adjunct Associate Professor
Interests: Translational, early- and late-stage clinical development programs encompassing biologics and chemical entities, cell and gene therapies, and digital therapeutics
Michael Derelanko, PhD
Senior Toxicologist / EHS Group Leader, Knoell USA, LLC
Interests: Toxicology
mjderel@gmail.com
Timi Edeki, MD, PhD*
Global Program Lead, Bristol Myers Squibb
Interests: Drug disposition and response; botanical-drug interactions; personalized medicine and pharmacogenomics
Melissa Egbertson, PhD
Self-employed Consultant
Interests: Medicinal chemistry, HIV, pain
melissaegbertson@gmail.com
Maciej Gasior, MD, PhD*
Vice President, Clinical Development Marinus Pharma
Interests: In vivo neuropsychopharmacology; behavioral pharmacology; addiction; epilepsy; pain
nextpharma@gmail.com
Alessandro Graziano, PhD
Adjunct Assistant Professor
Interests: Mechanisms of CNS plasticity, pain after spinal cord injury, chronic pain
ag699@drexel.edu
Pamela Hornby, PhD
Self-employed Consultant
Interests: Pharmacology and drug discovery
Jay Horrow, MD*
Clinical Professor, Anesthesiology & Critical Care Medicine, University of Pennsylvania
Interests: Drug discovery; medical pharmacology; neuromuscular blockers
jhorrow@gmail.com
Peter H. Hutson, PhD
Executive Director, Acadia Pharmaceuticals, Inc.
Interests: Neuropharmacology; psychiatric disorders; sleep
petehutson2@gmail.com
Bruce Jones, PhD
President and CEO, Score Pharma
Interests: Biologics
bejonesphd@gmail.com
Patrick Y. Lam, PhD
Distinguished Professor of Medicinal Chemistry, Baruch S. Blumberg Institute
Interests: Medicinal chemistry and drug development
patrick.ys.lam@gmail.com
Michael Liebman, PhD
President, IPQ Analytics LLC
Interests: Informatic technology
michael.liebman@drexelmed.edu
Michael J. Marino, PhD
Scientific Director, Merck Research Laboratories
Interests: Psychiatric disorders; CNS drug discovery
michael.marino@merck.com
Eliot Ohlstein, PhD
President & Head, Research and Development, Personal Therapeutics LLC
Interests: Drug discovery and development
eliot@altherx.com
Patrick Osei-Owusu, PhD
Associate Professor, Department of Physiology and Biophysics, Case Western Reserve University
Interests: Mechanisms of G-protein signaling regulation in physiological and pathophysiological adaptations of the cardiovascular and renal systems
patrick.osei-owusu@case.edu
Jeffrey Paul, PhD
Principal, JPharm Consulting
Background: Wyeth, Pfizer
Interests: Clinical pharmacology
MaryAnn Pelleymounter, PhD
Program Director, Division of Translational Research, National Institute of Neurological Disorders and Stroke
Interests: Drug discovery, obesity, translational research
pelleymounterm@yahoo.com
Rajesh Ranganathan, PhD
Vice President & Head, Corporate Development, Sun Pharma Advanced Research Company
Interests: Translational science, neurotherapeutics and education
Robert Ring, PhD
Chief Executive Officer, Kaerus Bioscience
Background: Wyeth Research, Pfizer
Interests: Autism spectrum disorders research; mood disorders research; drug discovery and development, and neuropeptide research
rob.ring.phd@gmail.com
Sharon Rosenzweig-Lipson, PhD
Chief Scientific Officer, Life Biosciences
Interests: Translational medicine; in vivo models; drug discovery
ivs.srlipson@gmail.com
James Samanen, PhD
Consultant, James Samanen Consulting LLC
Interests: Drug discovery and development
jamessamanen@gmail.com
Nathaniel W. Snyder, PhD
Associate Professor, Lewis Katz School of Medicine/Drexel University
Interests: Autism, pharmacology, analytical chemistry with an emphasis on liquid chromatography-mass spectrometry (LC-MS)
natewsnyder@temple.edu
David Stone, PhD
Vice President, Genetics and Target Identification, Cerevel Therapeutics
Interests: Genomics
david.stone@cerevel.com
Patrick Viatour, PhD
Adjunct Associate Professor; Associate Professor, Lankenau Institute for Medical Research
Interests: Cancer and inflammation, cancer therapeutic strategies
Michael W. Wood, PhD
Senior Vice President, MapLight Therapeutics
Interests: Neuroscience drug discovery, strategic out-licensing and business development
michael.wood@neuropharm.net
* Physician's practice is independent of Drexel Medicine and Drexel University College of Medicine.
Back to Top